Additionally, in accordance with discoveries of Perri et al. in thyroid cancer cells [26], OCT1-interfering CRC cell lines exhibited impaired proliferative potency both in vitro and in vivo. This evidence concerns the gene POU2F1 and colorectal carcinoma.